XML 18 R5.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
OPERATING ACTIVITIES:    
Net (Loss) Income $ (26,379) $ 47,907
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 103,304 92,527
Non-cash impairment charges 12,173 0
Deferred income tax (benefit) provision (13,743) 2,963
Share-based compensation 17,225 14,350
Amortization of debt issuance costs and expenses associated with debt refinancing 4,193 4,731
Non-cash lease expense (129) 2,120
Loss (gain) on disposal of property and equipment 1,337 (4)
Change in fair value of contingent consideration and others (319) 8,278
Changes in assets and liabilities:    
Accounts receivable 38,861 5,050
Inventories (27,579) (43,350)
Prepaid expenses and other current assets (34,401) (21,700)
Other non-current assets (1,745) (8,774)
Accounts payable, accrued expenses and other current liabilities 2,686 (22,141)
Contract liabilities 1,822 141
Other non-current liabilities 1,336 (893)
Net cash provided by operating activities 78,642 81,205
INVESTING ACTIVITIES:    
Purchases of property and equipment (74,818) (42,330)
Cash (paid) for business acquisitions, net of cash acquired (281,994) 0
Purchases of short term investments (48,997) 0
Proceeds from maturities of short term investments 19,250 0
Net proceeds from swaps designated as net investment hedges 0 5,381
Net cash used in investing activities (386,559) (36,949)
FINANCING ACTIVITIES:    
Proceeds from borrowings of long-term indebtedness 451,100 146,900
Payments on debt (147,188) (85,900)
Payment of debt issuance costs 0 (7,578)
Purchases of treasury stock (50,000) (275,000)
Payments for Contingent Consideration (11,923) 0
Proceeds from exercised stock options 6,398 4,092
Cash taxes paid in net equity settlement (3,374) (5,549)
Net cash provided by (used in) financing activities 245,013 (223,035)
Effect of exchange rate changes on cash and cash equivalents 1,659 (4,150)
Net decrease in cash and cash equivalents (61,245) (182,929)
Cash and cash equivalents at beginning of period 276,402 456,661
Cash and cash equivalents at end of period $ 215,157 $ 273,732